COVID-19 Pandemic: Vaccination Status in Africa
Despite the COVAX program, the availability of vaccine doses in Africa remains insufficient. We take a look at the COVID-19 vaccination status across Africa.
COVID-19 Vaccination Status in Africa
Thanks to the COVAX initiative by the WHO, aimed at fair vaccine distribution, 47 African countries had received vaccines by the end of April 2021. However, the available doses remain insufficient, with urgent need for more supplies.
Progress of Vaccination in Africa
- Ghana and Ivory Coast were among the first to receive AstraZeneca doses from COVAX.
- South Africa, the most affected country on the continent, prioritized healthcare workers in its first phase.
- The goal remains to immunize 67% of Africa’s population by the end of 2021.
Vaccine Shortages
- Less than 2% of global COVID-19 vaccines have been administered in Africa.
- Despite 17.21% of the world’s population being in Africa, vaccine distribution remains uneven.
Global Support for Africa
- The African Union's AVATT program secured 300 million Sputnik V doses from Russia.
- Johnson & Johnson committed 400 million doses to Africa by 2022.
- China’s vaccines are already in use in countries like Mozambique.
Low Infection Rates but Challenges Remain
- Africa has fared better than expected, with 4.57 million cases and 122,561 deaths as of May 4, 2021.
- Strict measures like travel bans, curfews, and gathering restrictions helped contain the virus.
- Lower mobility and a young population (average age 18 years) contributed to fewer deaths.
- However, testing remains limited, leading to concerns about unreported cases.
Despite these challenges, Africa has seen advancements in e-learning, remote work, and digital innovation due to the pandemic.